Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan 21:4:1.
doi: 10.3389/fonc.2014.00001. eCollection 2014.

Radiotherapy and the tumor stroma: the importance of dose and fractionation

Turid Hellevik  1 , Iñigo Martinez-Zubiaurre  2
Affiliations
Review

Radiotherapy and the tumor stroma: the importance of dose and fractionation

Turid Hellevik et al. Front Oncol. .

Abstract

Ionizing radiation is a non-specific but highly effective way to kill malignant cells. However, tumor recurrence sustained by a minor fraction of surviving tumor cells is a commonplace phenomenon caused by the activation of both cancer cell intrinsic resistance mechanisms, and also extrinsic intermediaries of therapy resistance, represented by non-malignant cells and structural components of the tumor stroma. The improved accuracy offered by advanced radiotherapy (RT)-technology permits reduced volume of healthy tissue in the irradiated field, and has been triggering an increase in the prescription of high-dose oligo-fractionated regimens in the clinics. Given the remarkable clinical success of high-dose RT and the current therapeutic shift occurring in the field, in this review we revise the existing knowledge on the effects that different radiation regimens exert on the different compartments of the tumor microenvironment, and highlight the importance of anti-tumor immunity and other tumor cell extrinsic mechanisms influencing therapeutic responses to high-dose radiation.

Keywords: angiogenesis; cancer-associated fibroblasts; cancer-immunity; hypoxia; stereotactic ablative radiotherapy; tumor microenvironment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer (2004) 4:737–4710.1038/nrc1451 - DOI - PubMed
    1. Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer (2011) 11:239–5310.1038/nrc3007 - DOI - PubMed
    1. De Ruysscher D, Belderbos J, Reymen B, van Elmpt W, van Baardwijk A, Wanders R, et al. State of the art radiation therapy for lung cancer 2012: a glimpse of the future. Clin Lung Cancer (2013) 14:89–9510.1016/j.cllc.2012.06.006 - DOI - PubMed
    1. Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, et al. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol (2010) 7:44–5410.1038/nrclinonc.2009.188 - DOI - PubMed
    1. Salama JK, Kirkpatrick JP, Yin FF. Stereotactic body radiotherapy treatment of extracranial metastases. Nat Rev Clin Oncol (2012) 9:654–6510.1038/nrclinonc.2012.166 - DOI - PubMed